In-depth interviews and an online survey found support for gene therapy as a treatment for inherited blood disorders, but ...

Lucy van de Wiel, PhD, discusses how in vitro fertilization (IVF) has evolved since its first successful use in 1978, ...

Scemblix (asciminib) is a new first-line option for adults with newly diagnosed Philadelphia chromosome-positive chronic ...

Regulators are also reviewing Teva’s application for its Prolia biosimilar candidate. The FDA’s decisions are expected ...

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

David Maahs, M.D., M.A., Ph.D., explains the role that teamwork, targets, technology and tight control plays in type 1 ...

David Maahs, M.D., M.A., Ph.D., explains why teamwork is the most important part of the 4T diabetes management program.

A single-center retrospective study found the approval and use of new agents to treat chronic graft-versus-host disease (GVHD ...

Type 1 diabetes is a relentless disease, according to David Maahs, M.D., M.A., Ph.D., from Stanford University.

Artificial intelligence stands out as a particularly promising solution to the challenges of improving health literacy.

Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with ...

Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently reviewing the oral therapy as an adjunct to insulin to help control glycemic ...